An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury
The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).
• Age 12 years or older at the time of enrollment.
• Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
• Willing and able to complete all required study visits and test assessments.
• Subjects with no history of traumatic brain injury (normal arm).
• Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).